Literature DB >> 14519657

Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis.

Jean Lud Cadet1, Subramaniam Jayanthi, Xiaolin Deng.   

Abstract

Methamphetamine (METH) is a drug of abuse that has long been known to damage monoaminergic systems in the mammalian brain. Recent reports have provided conclusive evidence that METH can cause neuropathological changes in the rodent brain via apoptotic mechanisms akin to those reported in various models of neuronal death. The purpose of this review is to provide an interim account for a role of oxygen-based radicals and the participation of transcription factors and the involvement of cell death genes in METH-induced neurodegeneration. We discuss data suggesting the participation of endoplasmic reticulum and mitochondria-mediated activation of caspase-dependent and -independent cascades in the manifestation of METH-induced apoptosis. Studies that use more comprehensive approaches to gene expression profiling should allow us to draw more instructive molecular portraits of the complex plastic and degenerative effects of this drug.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14519657     DOI: 10.1096/fj.03-0073rev

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  100 in total

1.  Extended findings of brain metabolite normalization in MA-dependent subjects across sustained abstinence: a proton MRS study.

Authors:  Ruth Salo; Michael H Buonocore; Martin Leamon; Yutaka Natsuaki; Christy Waters; Charles D Moore; Gantt P Galloway; Thomas E Nordahl
Journal:  Drug Alcohol Depend       Date:  2010-08-23       Impact factor: 4.492

2.  The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum.

Authors:  David M Thomas; Mariana Angoa Pérez; Dina M Francescutti-Verbeem; Mrudang M Shah; Donald M Kuhn
Journal:  J Neurochem       Date:  2010-09-06       Impact factor: 5.372

3.  Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings.

Authors:  Mariana Cherner; Chad Bousman; Ian Everall; Daniel Barron; Scott Letendre; Florin Vaida; J Hampton Atkinson; Robert Heaton; Igor Grant
Journal:  J Int Neuropsychol Soc       Date:  2010-08-23       Impact factor: 2.892

4.  Neuropsychological deficits in adolescent methamphetamine abusers.

Authors:  George King; Daniel Alicata; Christine Cloak; Linda Chang
Journal:  Psychopharmacology (Berl)       Date:  2010-07-17       Impact factor: 4.530

Review 5.  Nucleus accumbens invulnerability to methamphetamine neurotoxicity.

Authors:  Donald M Kuhn; Mariana Angoa-Pérez; David M Thomas
Journal:  ILAR J       Date:  2011

6.  Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice.

Authors:  J P Q Zhu; W Xu; J A Angulo
Journal:  Neuroscience       Date:  2006-05-02       Impact factor: 3.590

Review 7.  Neurotoxicology of Synthetic Cathinone Analogs.

Authors:  Mariana Angoa-Pérez; John H Anneken; Donald M Kuhn
Journal:  Curr Top Behav Neurosci       Date:  2017

8.  Hydrogen Sulfide Protects Hippocampal Neurons Against Methamphetamine Neurotoxicity Via Inhibition of Apoptosis and Neuroinflammation.

Authors:  Fateme Ghanbari; Mehdi Khaksari; Golamhassan Vaezi; Vida Hojati; Abdolhossein Shiravi
Journal:  J Mol Neurosci       Date:  2018-11-19       Impact factor: 3.444

9.  Lack of hydroxyl radical generation upon central administration of methamphetamine in rat caudate nucleus: a microdialysis study.

Authors:  Frederico C Pereira; Tice R Macedo; Syed Z Imam; Carlos F Ribeiro; Syed F Ali
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

10.  Diadenosine tetraphosphate reduces toxicity caused by high-dose methamphetamine administration.

Authors:  Brandon K Harvey; Jenny Chou; Hui Shen; Barry J Hoffer; Yun Wang
Journal:  Neurotoxicology       Date:  2009-02-13       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.